🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/11/2015 24,78 25,97 24,30 25,83 +3,86% 6,74% 1.100.700
12/11/2015 25,56 25,88 24,82 24,87 -3,64% 4,15% 690.300
11/11/2015 26,27 26,48 25,71 25,81 -1,83% 2,93% 767.200
10/11/2015 26,16 26,64 25,70 26,29 +0,15% 3,59% 874.600
09/11/2015 24,73 26,55 24,58 26,25 +5,51% 7,97% 1.224.700
06/11/2015 24,19 25,00 23,26 24,88 +2,47% 7,19% 1.218.900
05/11/2015 24,76 25,00 23,09 24,28 -3,15% 7,71% 1.668.200
04/11/2015 25,62 25,99 24,62 25,07 -2,41% 5,35% 1.389.300
03/11/2015 25,48 26,23 25,08 25,69 +0,12% 4,51% 1.186.500
02/11/2015 24,27 25,80 23,91 25,66 +6,65% 7,79% 1.254.200
30/10/2015 24,57 24,98 23,65 24,06 -2,31% 5,41% 1.697.900
29/10/2015 25,00 26,10 24,57 24,63 -2,26% 6,12% 1.362.900
28/10/2015 24,58 25,27 23,82 25,20 +1,25% 5,90% 1.052.700
27/10/2015 25,01 25,84 24,25 24,89 +0,16% 6,36% 990.400
26/10/2015 24,98 25,86 24,53 24,85 -0,52% 5,32% 1.144.000
23/10/2015 25,01 25,71 24,40 24,98 +3,10% 5,24% 1.692.800
22/10/2015 26,01 26,32 23,80 24,23 -6,56% 9,69% 2.237.700
21/10/2015 26,80 27,25 25,25 25,93 -3,03% 7,46% 1.497.600
20/10/2015 27,32 27,45 26,27 26,74 -2,48% 4,32% 1.776.500
19/10/2015 27,58 28,67 27,01 27,42 -1,83% 6,02% 1.751.500
16/10/2015 28,46 29,37 27,39 27,93 -0,99% 6,96% 2.135.300
15/10/2015 29,28 29,43 27,02 28,21 -2,92% 8,23% 3.744.600
14/10/2015 32,55 33,10 28,94 29,06 -11,78% 12,78% 9.318.800
13/10/2015 34,71 35,50 32,77 32,94 -5,40% 7,87% 1.817.100
12/10/2015 37,15 37,38 34,40 34,82 -6,12% 8,02% 1.648.100
09/10/2015 37,74 38,65 37,02 37,09 -1,90% 4,32% 810.300
08/10/2015 37,71 38,59 36,34 37,81 -0,42% 5,97% 1.159.400
07/10/2015 38,08 39,03 37,19 37,97 -0,08% 4,83% 1.551.400
06/10/2015 40,01 40,68 35,77 38,00 -9,07% 12,27% 5.968.500
05/10/2015 40,00 41,97 39,33 41,79 +5,56% 6,60% 2.320.500